Key Points
- CFO Jon Christian Bates purchased 750 shares at $136.71 each for $102,532.50, increasing his ownership by 15.34% to 5,638 shares, according to an SEC filing.
- Quarterly results beat expectations sharply, with EPS of $7.76 versus a consensus loss of ($5.43) and revenue of $243.99 million versus $221.93 million estimated, alongside a 42.08% ROE and 10.76% net margin.
- The stock was trading up about 4%, the company has a market cap of roughly $829 million and a P/E of 9.86, and analysts have raised ratings and set an average price target of about $252.50.
Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) CFO Jon Christian Bates purchased 750 shares of the business's stock in a transaction on Tuesday, November 25th. The stock was purchased at an average cost of $136.71 per share, with a total value of $102,532.50. Following the completion of the acquisition, the chief financial officer owned 5,638 shares in the company, valued at approximately $770,770.98. This trade represents a 15.34% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website.
Nutex Health Trading Up 4.0%
Nutex Health stock opened at $117.28 on Friday. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.26 and a current ratio of 2.27. Nutex Health Inc. has a fifty-two week low of $28.12 and a fifty-two week high of $184.27. The stock has a market cap of $829.40 million, a P/E ratio of 9.86 and a beta of -0.23. The firm's fifty day moving average price is $112.98 and its 200-day moving average price is $113.45.
Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings data on Tuesday, November 18th. The company reported $7.76 earnings per share (EPS) for the quarter, beating the consensus estimate of ($5.43) by $13.19. Nutex Health had a return on equity of 42.08% and a net margin of 10.76%.The company had revenue of $243.99 million during the quarter, compared to analyst estimates of $221.93 million.
Hedge Funds Weigh In On Nutex Health
Large investors have recently modified their holdings of the company. Topline Capital Management LLC lifted its position in Nutex Health by 80.0% in the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company's stock worth $57,505,000 after buying an additional 247,436 shares during the last quarter. Pertento Partners LLP purchased a new position in shares of Nutex Health during the third quarter worth approximately $27,940,000. Vanguard Group Inc. lifted its holdings in shares of Nutex Health by 12.7% in the 3rd quarter. Vanguard Group Inc. now owns 214,954 shares of the company's stock worth $22,209,000 after acquiring an additional 24,275 shares during the last quarter. American Century Companies Inc. boosted its stake in shares of Nutex Health by 39.9% in the 2nd quarter. American Century Companies Inc. now owns 104,063 shares of the company's stock valued at $12,955,000 after purchasing an additional 29,704 shares in the last quarter. Finally, Marshall Wace LLP grew its holdings in shares of Nutex Health by 333.4% during the 2nd quarter. Marshall Wace LLP now owns 94,548 shares of the company's stock valued at $11,770,000 after purchasing an additional 72,734 shares during the last quarter. 5.32% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
NUTX has been the subject of several recent analyst reports. Wall Street Zen raised Nutex Health from a "buy" rating to a "strong-buy" rating in a report on Friday. Weiss Ratings upgraded shares of Nutex Health from a "sell (d)" rating to a "hold (c)" rating in a research report on Tuesday. Finally, Maxim Group set a $205.00 price target on shares of Nutex Health and gave the stock a "buy" rating in a research note on Tuesday, August 26th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Nutex Health currently has an average rating of "Moderate Buy" and an average price target of $252.50.
Check Out Our Latest Stock Report on NUTX
About Nutex Health
(
Get Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
